Veerhealth Care Limited (BOM:511523)
India
· Delayed Price · Currency is INR 15.09
+0.56 (3.85%)
At close: May 27, 2025
Veerhealth Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 139.95 | 132.23 | 132.73 | 96.26 | 105.8 | 117.28 | Upgrade
|
| Other Revenue | 9.86 | 9.9 | 9.41 | 11.73 | 7.9 | 0.22 | Upgrade
|
| Revenue | 149.81 | 142.13 | 142.14 | 107.99 | 113.7 | 117.5 | Upgrade
|
| Revenue Growth (YoY) | 1.29% | -0.00% | 31.62% | -5.02% | -3.23% | 96.34% | Upgrade
|
| Cost of Revenue | 93.51 | 92.56 | 94.75 | 71.27 | 75.16 | 79.3 | Upgrade
|
| Gross Profit | 56.3 | 49.57 | 47.39 | 36.73 | 38.54 | 38.2 | Upgrade
|
| Selling, General & Admin | 19.01 | 15.38 | 12.87 | 11.79 | 8.28 | 8.89 | Upgrade
|
| Other Operating Expenses | 23.35 | 18.2 | 20.14 | 21.41 | 21.7 | 22.3 | Upgrade
|
| Operating Expenses | 50.6 | 40.69 | 39.22 | 38.44 | 34.65 | 34.42 | Upgrade
|
| Operating Income | 5.7 | 8.88 | 8.17 | -1.72 | 3.89 | 3.78 | Upgrade
|
| Interest Expense | -1.21 | - | - | -0.45 | -2.11 | -1.26 | Upgrade
|
| Interest & Investment Income | 3.99 | 3.99 | 2.99 | 4.94 | 4.07 | 4.6 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | -0.08 | -0.01 | -0.41 | -0.08 | -0.64 | Upgrade
|
| EBT Excluding Unusual Items | 8.41 | 12.8 | 11.14 | 2.38 | 5.77 | 6.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.03 | - | - | - | Upgrade
|
| Other Unusual Items | 0.02 | - | - | - | - | - | Upgrade
|
| Pretax Income | 8.44 | 12.82 | 11.17 | 2.38 | 5.77 | 6.47 | Upgrade
|
| Income Tax Expense | 8.62 | 8.75 | -4.65 | 3.11 | 1.98 | 3.29 | Upgrade
|
| Net Income | -0.18 | 4.06 | 15.82 | -0.74 | 3.79 | 3.18 | Upgrade
|
| Net Income to Common | -0.18 | 4.06 | 15.82 | -0.74 | 3.79 | 3.18 | Upgrade
|
| Net Income Growth | - | -74.33% | - | - | 19.13% | 101.20% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 20 | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | -19.97% | - | 44.20% | - | 0.00% | -0.00% | Upgrade
|
| EPS (Basic) | -0.01 | 0.20 | 0.79 | -0.05 | 0.27 | 0.23 | Upgrade
|
| EPS (Diluted) | -0.01 | 0.20 | 0.79 | -0.05 | 0.27 | 0.23 | Upgrade
|
| EPS Growth | - | -74.33% | - | - | 19.13% | 101.21% | Upgrade
|
| Free Cash Flow | - | 20.7 | -27.85 | 2.25 | 5.06 | -24.81 | Upgrade
|
| Free Cash Flow Per Share | - | 1.03 | -1.39 | 0.16 | 0.36 | -1.79 | Upgrade
|
| Gross Margin | 37.58% | 34.88% | 33.34% | 34.01% | 33.89% | 32.51% | Upgrade
|
| Operating Margin | 3.81% | 6.25% | 5.75% | -1.59% | 3.42% | 3.21% | Upgrade
|
| Profit Margin | -0.12% | 2.86% | 11.13% | -0.68% | 3.33% | 2.71% | Upgrade
|
| Free Cash Flow Margin | - | 14.56% | -19.59% | 2.08% | 4.45% | -21.11% | Upgrade
|
| EBITDA | 13.49 | 16 | 14.39 | 3.53 | 8.57 | 7.01 | Upgrade
|
| EBITDA Margin | 9.00% | 11.25% | 10.12% | 3.26% | 7.54% | 5.96% | Upgrade
|
| D&A For EBITDA | 7.79 | 7.12 | 6.22 | 5.24 | 4.68 | 3.23 | Upgrade
|
| EBIT | 5.7 | 8.88 | 8.17 | -1.72 | 3.89 | 3.78 | Upgrade
|
| EBIT Margin | 3.81% | 6.25% | 5.75% | -1.59% | 3.42% | 3.21% | Upgrade
|
| Effective Tax Rate | 102.10% | 68.31% | - | 130.98% | 34.25% | 50.80% | Upgrade
|
| Revenue as Reported | 153.81 | 146.13 | 145.13 | 112.94 | 117.77 | 122.09 | Upgrade
|
| Advertising Expenses | - | 2.28 | 3.67 | 2.92 | 0.7 | 0.91 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.